UCB
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Belgium · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
Allée De La Recherche 60, Bruxelles Ande...Phone Number
+32 25599999Website
www.ucb.comRevenue
$8.8 BillionStock Symbol
UCBIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
1
1
1
About UCB
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928. The company specializes in the discovery, development, and commercialization of innovative medicines for people living with severe neurological and autoimmune conditions. UCB's core therapeutic focus spans neurology — including epilepsy and Parkinson's disease — and immunology, encompassing conditions such as rheumatoid arthritis, Crohn's disease, psoriasis, and axial spondyloarthritis. Its marketed product portfolio includes Cimzia, Vimpat, Keppra, Briviact, Neupro, Bimzelx, Evenity, and Fintepla, among others. The company operates in more than 40 countries, with its U.S. headquarters located in Smyrna, Georgia, and additional sites across the United States supporting clinical development, research, and policy functions. UCB integrates patient and caregiver insights directly into its research and development process, combining scientific innovation with a commitment to health equity and sustRead more
UCB Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UCB your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on UCB recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if UCB had a recent Job posting/layoffs
Product Launch: Get notified when UCB launches new products
Check if UCB has recently received funding, and reach out quickly before it becomes old news!
Check out if UCB is spiking on competitors!
UCB, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at UCB
Funding: Get notified immidiatlly once UCB has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Explore company insights
Get a deeper look into UCB's structure, leadership, and market position:
Company Profile Activity
Activity Insights
UCB is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
UCB is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about UCB.
UCB Tech Stack
A closer look at the technologies used by UCB
See more technologies
Most Recent Scoops
Project
UCB has announced that Bepanemab will advance into a confirmatory Phase 2 study, based on a strong efficacy signal observed in a subpopulation with low tau activity, despite the primary endpoint not being met in the proof-of-concept study.
Proof of Concept (POC)
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Pharmaceuticals, Clinical Operations
UCB News & Media
United Community Banks, Inc. (UCB) Discusses Completion of Strategic Initiatives and Sale of Navitas to Strengthen Financial Position Transcript
United Community Banks, Inc. (UCB) Discusses Completion of Strategic Initiatives and Sale of Navitas to Strengthen Financial Position September 8, 2026 9:00...UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
Ensuring patients have access to the medicines they need through long-term commitment to patients and scientific innovation Building on long-standing U.S. presence, expanded investments in research, manufacturing infrastructure, and highly skilled jobs will strengthen economic growth For...Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award
Recognition reflects employee feedback and comes as UCB expands its Georgia footprint through a $2 billion investment in a new biomanufacturing campus expected to create more than 330 jobs. ATLANTA, Aug. 16, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company with its U.S....Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) in patients two years of age and older.¹ Post hoc analysis of patients with LGS, transitioning from the randomized...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UCB
Sign Up For FreeTo access detailed company insights
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928. The company specializes in the discovery, development, and commercialization of innovative medicines for people living with severe neurological and autoimmune conditions. UCB's core therapeutic focus spans neurology — including epilepsy and Parkinson's di... Read More
